Conference Proceedings

Alternative Overexpression of NRF2 or MYC Defines a Subgroup of Poor Prognosis Acute Myeloid Leukemia and Suggests a Novel Therapeutic Strategy By Combined Bromodomain Inhibition and Forced NRF2 Pathway Activation

Giorgia Simonetti, Samantha Bruno, Carmine Onofrillo, Cristina Papayannidis, Giovanni Marconi, Michele Cavo, Lorenzo Montanaro, Giovanni Martinelli

Blood | AMER SOC HEMATOLOGY | Published : 2018


Funding Acknowledgements

Supported by: EHA Non-Clinical Junior Research Fellowship, ELN, AIL, AIRC, project Regione-Universita 2010-12 (L. Bolondi), FP7 NGS-PTL project, Fondazione del Monte BO e RA project.